Q1/2020 6/30/2019 EPS 39.910 ZacksConsensus N/A ActVsEst N/A - N/A

Dr. Reddy's Laboratories Ltd (RDY)
US:NYSE Investor Relations:
drreddys.com/investors
Company Research
Source: Wall Street Horizon

Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RDY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RDY alerts
High impacting Dr. Reddy's Laboratories Ltd news events
Weekly update
A roundup of the hottest topics
RDY
News
- Dr. Reddy's Laboratories (RDY): Among the Best Indian Stocks to Buy According to Billionaires [Yahoo! Finance]Yahoo! Finance
- Suboxone Market size to reach US$ 8, 410.7 Million by 2030, says Coherent Market Insights [Yahoo! Finance]Yahoo! Finance
- Antiviral Drugs Market Forecasts and Company Analysis 2025-2034 Featuring AbbVie, Aurobindo, BMS, Cipla, Dr. Reddy's, Gilead Sciences, GlaxoSmithKline, Janssen, Merck, Mylan, Pfizer, and Sun Pharma [Yahoo! Finance]Yahoo! Finance
- Trump's latest tariff threat ends brief reprieve for Indian pharma stocks [Yahoo! Finance Canada]Yahoo! Finance Canada
- Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast AsiaPR Newswire
RDY
Earnings
- 1/24/25 - Beat
RDY
Sec Filings
- 4/16/25 - Form 6-K
- 4/14/25 - Form 6-K
- 4/7/25 - Form 6-K
- RDY's page on the SEC website